DNA synthesis is required for reprogramming mediated by stem cell fusion

Cell. 2013 Feb 14;152(4):873-83. doi: 10.1016/j.cell.2013.01.012.

Abstract

Embryonic stem cells (ESCs) can instruct the conversion of differentiated cells toward pluripotency following cell-to-cell fusion by a mechanism that is rapid but poorly understood. Here, we used centrifugal elutriation to enrich for mouse ESCs at sequential stages of the cell cycle and showed that ESCs in S/G2 phases have an enhanced capacity to dominantly reprogram lymphocytes and fibroblasts in heterokaryon and hybrid assays. Reprogramming success was associated with an ability to induce precocious nucleotide incorporation within the somatic partner nuclei in heterokaryons. BrdU pulse-labeling experiments revealed that virtually all successfully reprogrammed somatic nuclei, identified on the basis of Oct4 re-expression, had undergone DNA synthesis within 24 hr of fusion with ESCs. This was essential for successful reprogramming because drugs that inhibited DNA polymerase activity effectively blocked pluripotent conversion. These data indicate that nucleotide incorporation is an early and critical event in the epigenetic reprogramming of somatic cells in experimental ESC-heterokaryons.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • B-Lymphocytes / cytology
  • Cell Fusion
  • Cell Nucleus / metabolism
  • Cellular Reprogramming
  • DNA Replication*
  • Embryonic Stem Cells / cytology
  • Embryonic Stem Cells / metabolism*
  • Fibroblasts / cytology
  • Humans
  • Induced Pluripotent Stem Cells / cytology*
  • Induced Pluripotent Stem Cells / metabolism*
  • Mice
  • Nucleotides / metabolism
  • Octamer Transcription Factor-3 / metabolism

Substances

  • Nucleotides
  • Octamer Transcription Factor-3
  • Pou5f1 protein, mouse